CIK 0001061983 · Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 943291317
- Phone
- (650) 624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- 4 Planned sale President & CEO sold 7,500 shares at $77.92 ($584,400)
- 8-K Event Other events
- 424B5 Offering Prospectus
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale EVP Research & Development sold 3,500 shares at $77.37 ($270,795)
- 424B5 Offering Prospectus
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 4,032 shares at $75.00 ($302,400)
- 4 Planned sale EVP, Chief Financial Officer sold 23,906 shares at $76.87 ($1,837,654)
- 4 Planned sale Director sold 20,000 shares at $75.97 ($1,519,400)
- 8-K Event Other events
- 4 Planned sale EVP, Chief Commercial Officer sold 11,333 shares at $77.25 ($875,474)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale EVP, Chief Commercial Officer sold 15,857 shares at $65.00 ($1,030,705)
- 4 Planned sale EVP, Chief Commercial Officer sold 15,000 shares at $63.26 ($948,900)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Planned sale President & CEO sold 7,500 shares at $59.62 ($447,150)
Page 5 of 127 · 2,534 filings